Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
The Oncologist
|
July 16, 2017
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults
Michael J Wagner, Vancheswaran Gopalakrishnan, Vinod Ravi, et al.
Gynecologic Oncology
|
June 28, 2017
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L Hensley, Shreyaskumar R Patel, Margaret von Mehren, et al.
Journal of Neurosurgery. Spine
|
April 29, 2017
The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis
Ganesh M Shankar, Michelle J Clarke, Tamir Ailon, et al.
Cancer Medicine
|
May 7, 2021
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model
Rashmi Chugh, J Kyle Wathen, Robert G Maki, et al.
Cancer
|
September 5, 2002
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
Funda Meric, Kenneth R Hess, Datla G K Varma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]
Robert G Maki, J Kyle Wathen, Shreyaskumar R Patel, et al.
BMC Cancer
|
September 26, 2018
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Emily Z Keung, Alexander J Lazar, Keila E Torres, et al.
Lancet (London, England)
|
February 15, 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Patrick Schöffski, Sant Chawla, Robert G Maki, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
The Oncologist
|
July 16, 2017
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults
Michael J Wagner, Vancheswaran Gopalakrishnan, Vinod Ravi, et al.
Gynecologic Oncology
|
June 28, 2017
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L Hensley, Shreyaskumar R Patel, Margaret von Mehren, et al.
Journal of Neurosurgery. Spine
|
April 29, 2017
The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis
Ganesh M Shankar, Michelle J Clarke, Tamir Ailon, et al.
Cancer Medicine
|
May 7, 2021
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model
Rashmi Chugh, J Kyle Wathen, Robert G Maki, et al.
Cancer
|
September 5, 2002
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
Funda Meric, Kenneth R Hess, Datla G K Varma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]
Robert G Maki, J Kyle Wathen, Shreyaskumar R Patel, et al.
BMC Cancer
|
September 26, 2018
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Emily Z Keung, Alexander J Lazar, Keila E Torres, et al.
Lancet (London, England)
|
February 15, 2016
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Patrick Schöffski, Sant Chawla, Robert G Maki, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
Page
of 10